Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone

@inproceedings{Warris2016AcuteAO,
  title={Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone},
  author={Lidewij T Warris and Erica L T van den Akker and Marc Bierings and Cor van den Bos and Christian Michel Zwaan and Sebastiaan D. T. Sassen and Wim J. E. Tissing and Margreet A. Veening and Rob Pieters and Marry M van den Heuvel-Eibrink},
  booktitle={PloS one},
  year={2016}
}
Although dexamethasone is highly effective in the treatment of pediatric acute lymphoblastic leukemia (ALL), it can cause serious metabolic side effects. Because studies regarding the effects of dexamethasone are limited by their small scale, we prospectively studied the direct effects of treating pediatric ALL with dexamethasone administration with respect to activation of components of metabolic syndrome (MetS); in addition, we investigated whether these side effects were correlated with the… CONTINUE READING
2
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 39 REFERENCES

Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia

JJ Reilly, BroughamM, +3 authors BE. Gibson
  • J Clin Endocrinol Metab
  • 2001
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…